OTCMKTS:INNV InnovAge (INNV) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free innv Stock Alerts $3.91 +0.11 (+2.89%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$3.84▼$4.1050-Day Range$3.80▼$5.1652-Week Range$3.80▼$8.05Volume8,567 shsAverage Volume23,521 shsMarket Capitalization$531.37 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Get InnovAge alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About InnovAge Stock (OTCMKTS:INNV)InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More INNV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INNV Stock News HeadlinesFebruary 22, 2024 | benzinga.comInnovAge Holding Stock (NASDAQ:INNV) Earnings Dates and Earning CallsFebruary 9, 2024 | finance.yahoo.comAnalysts Have Made A Financial Statement On InnovAge Holding Corp.'s (NASDAQ:INNV) Second-Quarter ReportApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 8, 2024 | au.finance.yahoo.comCar-sharing company Getaround cuts one-third of US workforceFebruary 8, 2024 | au.lifestyle.yahoo.comSingapore Takes Large Stake in Kohl’sFebruary 8, 2024 | au.finance.yahoo.com8 Purchases Boomers Should Never Make During RetirementFebruary 8, 2024 | au.finance.yahoo.comUnilever takes sales hit in Indonesia over anti-Israel boycottsFebruary 8, 2024 | finance.yahoo.comInnovAge Holding Second Quarter 2024 Earnings: Beats ExpectationsApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 8, 2024 | finance.yahoo.comInnovAge to Host Investor Day on February 27, 2024February 5, 2024 | benzinga.comEarnings Outlook For InnovAge HoldingJanuary 23, 2024 | finance.yahoo.comInnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024December 1, 2023 | finance.yahoo.comInnovAge Announces Acquisition of ConcertoCare’s PACE ProgramsNovember 7, 2023 | finance.yahoo.comInnovAge Announces Financial Results For The Fiscal First Quarter Ended September 30, 2023September 13, 2023 | finance.yahoo.comInnovAge Holding Corp. (NASDAQ:INNV) Q4 2023 Earnings Call TranscriptSeptember 11, 2023 | benzinga.comEarnings Preview: InnovAge HoldingSeptember 10, 2023 | msn.comDow futures trade flat, fresh inflation data in focusSeptember 10, 2023 | msn.comINNVInnovAge Holding Corp.August 29, 2023 | finance.yahoo.comInnovAge to Announce Fiscal Fourth Quarter 2023 Financial Results and Host Conference Call Tuesday, September 12, 2023August 16, 2023 | benzinga.comPerformance Food Group, Stride, Progressive, H&R Block And Other Big Stocks Moving Higher On WednesdayAugust 14, 2023 | finance.yahoo.comInnovAge Strengthens Board with Appointment of New Independent DirectorJuly 6, 2023 | bizjournals.comInnovAge taps former health care investment banker for newly vacated CFO roleJuly 5, 2023 | finance.yahoo.comInnovAge Names Ben Adams as New Chief Financial OfficerJuly 5, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of InnovAge Holding Corp. (NASDAQ:INNV)June 27, 2023 | msn.comInnovAge Holding: EBITDA In Focus With No More SanctionsJune 16, 2023 | msn.comInnovAge Holding: Gross Productivity, Multiples Speak VolumesJune 8, 2023 | finance.yahoo.comInnovAge Holding (NASDAQ:INNV) soars 17% this week, taking one-year gains to 48%See More Headlines Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today4/27/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:INNV Previous SymbolNASDAQ:INNV CUSIPN/A CIK1411879 Webwww.innovuspharma.com Phone844-803-8745FaxN/AEmployees2,100Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+79.0%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,520,000.00 Net Margins-6.17% Pretax Margin-7.63% Return on Equity-13.04% Return on Assets-7.48% Debt Debt-to-Equity Ratio0.25 Current Ratio1.57 Quick Ratio1.57 Sales & Book Value Annual Sales$720.80 million Price / Sales0.74 Cash Flow$0.06 per share Price / Cash Flow65.41 Book Value$2.50 per share Price / Book1.56Miscellaneous Outstanding Shares135,899,000Free Float135,311,000Market Cap$531.37 million OptionableNot Optionable Beta0.15 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Patrick Blair (Age 53)President & CEO Comp: $1.51MMs. Nicole D'Amato (Age 45)Chief Legal Officer & Corporate Secretary Comp: $678.76kDr. Richard A. Feifer FACP (Age 57)M.D., M.P.H., Chief Medical Officer Comp: $588.97kMr. Edward Moore Kennedy Jr. (Age 63)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 62)R.N., Independent Director Comp: $120kMr. Benjamin Crowninshield Adams (Age 60)Chief Financial Officer Ms. Christine Bent (Age 53)Chief Operations Officer Ms. Cara BabachicosChief Information OfficerMr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMore ExecutivesKey CompetitorsOmniAbNASDAQ:OABIJin Medical InternationalNASDAQ:ZJYLKorro BioNASDAQ:KRROValnevaNASDAQ:VALNCalliditas Therapeutics AB (publ)NASDAQ:CALTView All CompetitorsInsidersNicole DamatoSold 1,866 sharesTotal: $13,192.62 ($7.07/share)Nicole DamatoSold 411 sharesTotal: $2,909.88 ($7.08/share)Nicole DamatoSold 6,422 sharesTotal: $45,596.20 ($7.10/share)Nicole DamatoSold 4,173 sharesTotal: $30,379.44 ($7.28/share)Nicole DamatoSold 2,101 sharesTotal: $15,253.26 ($7.26/share)View All Insider Transactions INNV Stock Analysis - Frequently Asked Questions What is InnovAge's stock price target for 2024? 0 brokerages have issued 1 year price targets for InnovAge's stock. Their INNV share price targets range from $7.00 to $7.00. On average, they predict the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 79.0% from the stock's current price. View analysts price targets for INNV or view top-rated stocks among Wall Street analysts. How have INNV shares performed in 2024? InnovAge's stock was trading at $6.00 at the start of the year. Since then, INNV shares have decreased by 34.8% and is now trading at $3.91. View the best growth stocks for 2024 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (OTCMKTS:INNV) released its quarterly earnings data on Tuesday, February, 6th. The company reported ($0.03) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.03). The firm earned $188.90 million during the quarter, compared to analyst estimates of $181.51 million. InnovAge had a negative net margin of 6.17% and a negative trailing twelve-month return on equity of 13.04%. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some companies that other InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Federal National Mortgage Association (FNMA), Medicines (MDCO), Frontier Communications (FTR), FedEx (FDX), Republic First Bancorp (FRBK), Aytu BioPharma (AYTU), NVIDIA (NVDA) and Pacific Premier Bancorp (PPBI). How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:INNV) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.